The Swiss Medtech National Regulatory Conference is a leading Swiss event dedicated to regulatory developments and compliance challenges affecting the medical technology industry. Organized by Swiss Medtech, the conference brings together medtech executives, regulatory affairs specialists, quality professionals, manufacturers, policymakers, industry experts and other stakeholders to examine the changing regulatory landscape and its impact on medical technology companies.
The conference provides a practical platform for understanding the latest developments in Swiss and European medical device regulation. Key areas include the EU Medical Device Regulation (MDR), international approval requirements, regulatory policy, market access, compliance and evolving requirements for medical technology companies operating in Switzerland and international markets.
Emerging technologies are an increasingly important part of the programme. Recent editions have addressed artificial intelligence, digitalisation and health data, examining how new technologies interact with existing regulatory frameworks and how medtech companies can adapt their processes and strategies. The conference also explores how regulatory requirements can become a strategic advantage rather than simply a compliance obligation.
Another important focus is sustainability and the changing business environment for the Swiss medtech sector. Discussions address regulatory developments, environmental requirements, international trade and the broader framework conditions influencing innovation and competitiveness. The programme combines strategic perspectives with practical examples from industry.
The National Regulatory Conference is designed around knowledge exchange and real-world experience. Participants can attend expert presentations, specialised breakout sessions and discussions covering current regulatory challenges. The event also provides valuable networking opportunities, allowing professionals from across the medical technology ecosystem to exchange experiences and develop industry connections.
The conference is particularly relevant for medical device manufacturers, regulatory affairs professionals, quality managers, compliance specialists, clinical and technical experts, healthcare technology companies, consultants and representatives of public authorities. With its industry-focused approach, it provides practical guidance for organisations seeking to understand regulatory changes and prepare for future requirements.
The Swiss Medtech National Regulatory Conference has evolved from the former MDR & IVDR Conference, reflecting a broader scope that now encompasses a wider range of regulatory issues affecting the medical technology sector. This expanded focus makes the event an important meeting point for professionals seeking current regulatory knowledge, practical solutions and strategic perspectives on the future of Swiss medtech.
